Make your money go further for just 25p per day

AIM IHT

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

Mulberry tree

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.


Fusion Antibodies: results underwhelm

Fusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m.

Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m.

They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Advanced Medical Solutions

Top performers from the retail sector

11/01/2023 · Company Insights

Results and updates covered here include news from two small AIM companies in the retail sector,…


Naked Wines plummets, others impress

14/09/2022 · Company Insights

Two unexpected announcements from online wine retailer Naked Wines suggest that all is not…


More on Argentex Group PLC

Plenty to encourage | Bonkers Bargain Upgrades

26/01/2023 · Company Insights

Results and trading updates from AIM covered in our free update here are generally positive and include plenty…


Bonkers Bargains: another upgrade

26/01/2023 · Company Insights

This business had delivered consistent growth over a number of years before the pandemic hit, but…


More on Frasers Group

Bonkers Bargain Mulberry still looks interesting to us

30/11/2022 · Company Insights

Having experienced a dramatic rise and fall over the past decade, Mulberry faces an uncertain future.…


Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

20/11/2020 · Company Insights

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…


More on Fusion Antibodies PLC

Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest

20/11/2020 · Company Insights

Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…


Coronavirus impact: 28 April - soaring share prices from this little lot

28/04/2020 · Company Insights

Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…


More Company Insights

AIM: a bright start to 2023

03/02/2023 · Celsius Resources

AIM elder is steady as ever | What’s in a name?

Stonking Small Caps: strong trading update

02/02/2023 · PCI- PAL PLC

Sign-up to our free email updates

SIGN UP